The shingles vaccine offers several important benefits for seniors, primarily by reducing the risk and severity of shingles and its potential complications:
1. Reduced Risk of Shingles: The shingles vaccine (Shingrix is the most common type in the U.S.) reduces the risk of developing shingles by over 90% in adults aged 50 and older. This is significant because shingles, caused by the reactivation of the varicella-zoster virus (the same virus that causes chickenpox), becomes more common with age, especially after 50.
2. Lower Risk of Postherpetic Neuralgia (PHN): One of the most serious complications of shingles is postherpetic neuralgia, a type of severe and persistent nerve pain that can last for months or even years after the shingles rash has healed. PHN can be debilitating and is more likely to affect seniors. Shingrix reduces the risk of PHN by about 90%.
3. Decreased Severity of Symptoms: For those who do develop shingles after getting vaccinated, the symptoms are often milder and shorter in duration. This can lead to a quicker recovery and less severe discomfort or pain.
4. Better Overall Health and Quality of Life: By reducing the likelihood of shingles and its complications, the vaccine helps seniors maintain their health and independence. Shingles can be painful and may disrupt daily activities, so preventing it helps seniors stay active and engaged.
5. Long-lasting Immunity: Shingrix is shown to provide strong immunity for at least four years, with studies suggesting it may last even longer. This lasting protection is particularly beneficial for seniors, who may be at risk for shingles for many years.
Because the immune system tends to weaken with age, seniors are at a higher risk of developing shingles and experiencing severe complications. The shingles vaccine is highly recommended for people aged 50 and older, especially those with weakened immune systems or underlying health conditions.
At Yuma Senior Living we have an onsite health clinic who can assist senior with many questions that they might have regarding the efficacy of vaccines.
Comments